Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NFIL3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CD28 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | TMEM39B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RP13-347D8.7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CHUK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZMAT3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | IL3RA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RNF113A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
mRNA | BOLA3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | BRS3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |